Publications of Institute of Radiopharmaceutical Cancer Research - Year 2023

8 Publications

2023

Development of a Highly Specific 18F-labeled Radioligand for Imaging of Sigma-2 Receptor in Brain Tumor

Wang, T.; Wang, J.; Chen, L.; Zhang, X.; Mou, T.; et al. (11 authors)

Radiosynthesis and biological evaluation of [¹⁸F]AG-120 for PET imaging of the mutant isocitrate dehydrogenase 1 in gliomas

Lai, T. H.; Wenzel, B.; Dukic-Stefanovic, S.; Teodoro, R.; Arnaud, L.; et al. (14 authors)

  • Open Access Logo European Journal of Nuclear Medicine and Molecular Imaging 51(2024), 1085-1096
    Online First (2023) DOI: 10.1007/s00259-023-06515-7

Development of the Highly Affine Carborane-Based Cannabinoid Receptor Type 2 PET Ligand [18F]LUZ5-d8

Ueberham, L.; Gündel, D.; Kellert, M.; Deuther-Conrad, W.; Ludwig, F.-A.; et al. (11 authors)

Radiofluorination of an anionic, azide-functionalized teroligomer by copper-catalyzed azide-alkyne cycloaddition

Wenzel, B.; Schmid, M.; Teodoro, R.; Moldovan, R.-P.; Lai, T. H.; et al. (11 authors)

Specific and safe targeting of glioblastoma using switchable and logic-gated RevCAR T cells

Abdelfatah Saleh Hassan, H. A.; Mitwasi, N.; Ullrich, M.; Kubeil, M.; Toussaint, M.; et al. (17 authors)

Nemacol is a Small Molecule Inhibitor of C. elegans Vesicular Acetylcholine Transporter with Anthelmintic Potential

Harrington, S.; Pyche, J.; Andrew, R. B.; Spalholz, T.; Ryan, K. T.; et al. (15 authors)

Selective a3b4 nicotinic acetylcholine receptor ligand as a potential tracer for drug addiction

Kanasuwan, A.; Deuther-Conrad, W.; Sarasamkan, J.; Chotipanich, C.; Vajragupta, O.; et al. (6 authors)

Synthesis, Structure–Activity Relationships, Radiofluorination, and Biological Evaluation of [18F]RM365, a Novel Radioligand for Imaging the Human Cannabinoid Receptor Type 2 (CB2R) in the Brain with PET

Teodoro, R.; Gündel, D.; Deuther-Conrad, W.; Toussaint, M.; Wenzel, B.; et al. (9 authors)

Full view width login